35 results on '"P388 leukemia"'
Search Results
2. Therapeutic Resistance in Leukemia
3. Murine L1210 and P388 Leukemias
4. Mouse Models in Cancer Drug Discovery and Development
5. Natural Pyranoacridones from Citrus and Sarcomelicope Species as Models for the Conception of New Antitumor Agents
6. Murine L1210 and P388 Leukemias
7. The Taxoids
8. Murine L1210 and P388 Leukemias
9. Metabolic Inactivation and Efflux of Daunorubicin as Complementary Mechanisms in Tumor Cell Resistance
10. Physiological Roles of Ectoenzymes Indicated by the Use of Aminopeptidase Inhibitors
11. Nucleoside and Nucleotide Modulation of Oncogenic Expression: A New Approach to Cancer Chemotherapy
12. Bropirimine, a Small-Molecule Biological Response Modifier and an Effective Antitumor Agent
13. Daphne genkwa Sieb. et Zucc.
14. Bioactive Polyethers
15. Growth Inhibition of Multidrug-Resistant Cells by Monoclonal Antibodies against P-Glycoprotein
16. Mitoxantrone in the Treatment of Acute Leukemia
17. Structure-Activity Relationships among Antitumour Quinones
18. Phase II Evaluation of N-Trifluoroacetyladriamycin-14-Valerate (AD 32)
19. Preliminary Experience with Marcellomycin: Preclinical and Clinical Aspects
20. Diethyldithiocarbamate and cis-Platinum Toxicity
21. Modes of Drug Resistance in Acute Leukemias
22. Metabolites of tiazofurin as mediators of its biochemical and pharmacologic effects
23. Laboratory aspects of multidrug resistance
24. Characteristics of an IA+ Antigen-Presenting Tumor Cell Line
25. The Effectiveness of Sequential Therapy Schedules with Adriamycin and Cyclophosphamide in the P388 Leukemia Model
26. Discovery and Development of Antineoplastic Agents from Natural Sources
27. The Preclinical Scientific Basis for Adjuvant Chemotherapy in Breast Cancer
28. New Anthracycline Antibiotic Aclacinomycin A: Experimental Studies and Correlations with Clinical Trials
29. Screening of Small Molecular Microbial Products Modulating Immune Responses and Bestatin
30. Current Status of Japanese Studies with the New Anthracycline Antibiotic Aclacinomycin A
31. m-AMSA: A New Anticancer Agent
32. In Vivo Antitumor Evaluation of Antibiotics. Selected Results from the Drug Evaluation Program of the National Cancer Institute, U.S.A
33. Clinical Evaluation of New Antitumor Antibiotics
34. Problems Related to the Detection of Activity of Antitumor Antibiotics
35. Cancer Drug Delivery Systems: Macromolecular Prodrugs of Mitomycin C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.